Search - tctmd.com

Displaying 381 - 400 of 2151

Sort: Relevancy | Date

News Industry News

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

May 01, 2019

News Industry News

Medtronic Announces U.S. Commercial Launch of Solitaire(TM) X Revascularization Device

April 30, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

News Daily News

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

Michael O'Riordan

April 02, 2019

News Daily News

FDA Warns of Cybersecurity Vulnerabilities With Some Medtronic Implanted Devices

Michael O'Riordan

March 22, 2019

News Conference News EHRA 2019

Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib

Todd Neale

March 20, 2019

News Conference News

WRAP IT: Novel Antibacterial ‘Envelope’ Reduces Rate of Infections From Implanted Cardiac Devices

L.A. McKeown

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Daily News

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

Todd Neale

March 14, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

News Daily News

Class I Recall for Certain Medtronic Pacemakers Due to Possible Circuit Error

Todd Neale

February 15, 2019

Advertisement

Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead

Medtronic Announces U.S. Commercial Launch of Solitaire(TM) X Revascularization Device

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

Latest Observational Data Support TAVR Durability Through 7 Years

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis

FDA Warns of Cybersecurity Vulnerabilities With Some Medtronic Implanted Devices

Streamlined Procedure Maintains Benefits of Cryoablation Over Drugs for Paroxysmal A-fib

WRAP IT: Novel Antibacterial ‘Envelope’ Reduces Rate of Infections From Implanted Cardiac Devices

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

TCTMD’s Top 10 Most Popular Stories for February 2019

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Class I Recall for Certain Medtronic Pacemakers Due to Possible Circuit Error

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content